Literature DB >> 13738700

The assay and properties of labile factor (factor V).

A J QUICK.   

Abstract

Human oxalated plasma stored at 4 degrees C. until the prothrombin time is increased beyond 60 sec. is a reliable medium for assaying labile factor (factor V) because its response to added labile factor corresponds quantitatively to that of plasma from patients with congenital deficiency of this factor. Such an agreement is not obtained with plasma stored at 37 degrees C. The stability of labile factor is closely associated with ionized calcium. The addition of thrombin to fresh oxalated plasma causes an apparent hyperactivity of labile factor, but this is completely removed by adsorption with Ca(3)(PO)(2). Oxalated plasma when adsorbed with Ca(3)(PO(4))(2) before treatment with thrombin does not develop this adventitious activity, nor does it occur in stored plasma treated with thrombin. The seemingly high labile factor activity in serum can be explained by the activation of this factor which is independent of labile factor but acts synergistically with it. The true labile factor concentration can be determined only after the accelerator is removed by adsorption with Ca(3)(PO(4))(2). A close agreement between the consumption of prothrombin and the loss of labile factor during clotting is observed.

Entities:  

Keywords:  BLOOD COAGULATION

Mesh:

Substances:

Year:  1960        PMID: 13738700      PMCID: PMC480121          DOI: 10.1136/jcp.13.6.457

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Hematologic and coagulation studies in various animal species.

Authors:  P DIDISHEIM; K HATTORI; J H LEWIS
Journal:  J Lab Clin Med       Date:  1959-06

2.  Factor-V consumption during blood coagulation.

Authors:  A S DOUGLAS
Journal:  Br J Haematol       Date:  1956-04       Impact factor: 6.998

3.  A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma.

Authors:  P WOLF
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

4.  HUMAN PROTHROMBIN: QUANTITATIVE STUDIES ON THE PLASMA LABILE FACTOR AND THE RESTORATIVE EFFECTS OF NORMAL, HYPOFI-BRINOGENEMIC, AND HEMOPHILIC PLASMA ON THE PROTHROMBIN OF STORED PLASMA.

Authors:  B Alexander; A De Vries; E Addelson
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

5.  A Prothrombin Conversion Accelerator in Serum.

Authors:  B Alexander; A de Vries; R Goldstein; G Landwehr
Journal:  Science       Date:  1949-05-27       Impact factor: 47.728

6.  Effect of sodium citrate and heparin on I removal of calcium from blood and serum by amberlite.

Authors:  C F CONSOLAZIO; F SARGENT; C V HUSSEY; A F QUICK; M STEFANINI; C F CONSOAZIO; F SARGENT
Journal:  J Biol Chem       Date:  1950-05       Impact factor: 5.157

7.  The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin.

Authors:  B ALEXANDER; R GOLDSTEIN; G LANDWEHR
Journal:  J Clin Invest       Date:  1950-07       Impact factor: 14.808

  7 in total
  5 in total

1.  "THROMBOCYTOPENIC SERUM": AN ARTIFICIAL FACTOR VIII-DEFICIENT REAGENT.

Authors:  E DAVIDSON; S TOMLIN
Journal:  J Clin Pathol       Date:  1964-03       Impact factor: 3.411

2.  The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide.

Authors:  R T Breckenridge; O D Ratnoff
Journal:  J Clin Invest       Date:  1965-02       Impact factor: 14.808

3.  The pathogenesis of leptospirosis I. Hemorrhages in experimental leptospirosis in guinea pigs.

Authors:  R Higgins; G Cousineau
Journal:  Can J Comp Med       Date:  1977-04

4.  Potentiation of endotoxin-induced consumptive coagulopathy by lead acetate administration.

Authors:  R B Jones; L A Kiesow
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

5.  The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons.

Authors:  R A Pixley; R De La Cadena; J D Page; N Kaufman; E G Wyshock; A Chang; F B Taylor; R W Colman
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.